CD28 and breast carcinoma: Similarly to what was reported for breast cancer patients, high peripheral CD8+CD28+ T-cell levels are linked to better overall survival (OS) and PFS in adenocarcinomas, whereas squamous cell carcinomas (SCCs) with a high frequency of CD8+CD28− T cells tend to have worse OS and PFS [51].